erythrosine has been researched along with calpain inhibitor iii in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Keith, CH; Kisaalita, WS; Wilson, MT | 1 |
Araújo, IM; Bahr, BA; Brundin, P; Carreira, BP; Carvalho, CM; Gil, JM; Mohapel, P; Petersen, A; Pinheiro, PS; Soulet, D | 1 |
2 other study(ies) available for erythrosine and calpain inhibitor iii
Article | Year |
---|---|
Glutamate-induced changes in the pattern of hippocampal dendrite outgrowth: a role for calcium-dependent pathways and the microtubule cytoskeleton.
Topics: Antineoplastic Agents; Calcium; Cell Survival; Cells, Cultured; Cysteine Proteinase Inhibitors; Cytoskeleton; Dendrites; Dipeptides; Enzyme Inhibitors; Fluoresceins; Glutamic Acid; Glycoproteins; Growth Cones; Hippocampus; Imidazoles; Microscopy, Fluorescence; Microtubule Proteins; Microtubules; Neurons; Nocodazole; Paclitaxel | 2000 |
Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus.
Topics: Animals; Calpain; Caspases; Convulsants; Dipeptides; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Epilepsy; Fluoresceins; Hippocampus; Kainic Acid; Male; Nerve Degeneration; Organic Chemicals; Rats; Rats, Wistar; Spectrin; Status Epilepticus; Time Factors | 2008 |